- Supported exchanges /
- AU /
- EMD.AU
Emyria Ltd (EMD AU) stock market data APIs
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops psychedelic-assisted therapy, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and mild stress and anxiety. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.
Emyria Ltd Financial Data Overview
0.038 | |
0.04 | |
- | |
0.04 | |
0.038 | |
0.027-0.087 | |
15 542 K | |
409 M | |
2 203 K | |
0.814 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Emyria Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 203 K
- EBITDA -3 160 181
- Earnings Per Share -0.03
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Emyria Ltd Earnings via APIs
- Latest Release 2024-08-30
- EPS/Forecast NaN
Get Emyria Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: